Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study - PubMed
- ️Sat Jan 01 2005
Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study
Ludger Tebartz van Elst et al. Biol Psychiatry. 2005.
Abstract
Background: Glutamatergic dysfunction has been implicated in the pathophysiology of schizophrenia. However, so far there is limited direct evidence of altered in vivo glutamate concentrations in the brains of patients with schizophrenia. To test the hypothesis that altered glutamatergic neurotransmission might play a role in the pathogenesis of schizophrenia, we measured glutamate and glutamine concentrations in the prefrontal cortex and the hippocampus of patients with chronic schizophrenia using high-field magnetic resonance spectroscopy.
Methods: Twenty-one patients with schizophrenia and 32 healthy volunteers were examined clinically and by means of short echo time single voxel magnetic resonance spectroscopy of the dorsolateral prefrontal cortex and the hippocampus. Absolute concentrations of neurometabolites were calculated.
Results: Absolute concentrations of glutamate were significantly higher in the prefrontal cortex and the hippocampus in the patient group. Factorial analysis of variance (ANOVA) revealed no significant interactions between duration of schizophrenia, number of hospitalizations, or type of antipsychotic medication and glutamate concentrations. Increased prefrontal glutamate concentrations were associated with poorer global mental functioning.
Conclusions: This is the first study that reports increased levels of glutamate in prefrontal and limbic areas in patients with schizophrenia. Our data support the hypothesis of glutamatergic dysfunction in schizophrenia.
Comment in
-
Théberge J, Jensen JE, Rowland LM. Théberge J, et al. Biol Psychiatry. 2007 May 15;61(10):1218-9; author reply 1219-20. doi: 10.1016/j.biopsych.2006.05.037. Epub 2006 Sep 1. Biol Psychiatry. 2007. PMID: 16950227 No abstract available.
Similar articles
-
Olbrich HM, Valerius G, Rüsch N, Buchert M, Thiel T, Hennig J, Ebert D, Van Elst LT. Olbrich HM, et al. World J Biol Psychiatry. 2008;9(1):59-63. doi: 10.1080/15622970701227811. World J Biol Psychiatry. 2008. PMID: 17853298
-
Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B. Ohrmann P, et al. J Psychiatr Res. 2007 Oct;41(8):625-34. doi: 10.1016/j.jpsychires.2006.07.002. Epub 2006 Sep 1. J Psychiatr Res. 2007. PMID: 16949099
-
Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Hasler G, et al. Arch Gen Psychiatry. 2007 Feb;64(2):193-200. doi: 10.1001/archpsyc.64.2.193. Arch Gen Psychiatry. 2007. PMID: 17283286
-
Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.
Nanitsos EK, Nguyen KT, St'astný F, Balcar VJ. Nanitsos EK, et al. J Biomed Sci. 2005 Dec;12(6):975-84. doi: 10.1007/s11373-005-9015-0. Epub 2005 Oct 14. J Biomed Sci. 2005. PMID: 16228297 Review.
-
Ohnuma T, Suzuki T, Arai H. Ohnuma T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):889-94. doi: 10.1016/j.pnpbp.2005.04.038. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15949884 Review.
Cited by
-
Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.
Davies C, Bossong MG, Martins D, Wilson R, Appiah-Kusi E, Blest-Hopley G, Allen P, Zelaya F, Lythgoe DJ, Brammer M, Perez J, McGuire P, Bhattacharyya S. Davies C, et al. Schizophr Bull Open. 2023 Aug 14;4(1):sgad022. doi: 10.1093/schizbullopen/sgad022. eCollection 2023 Jan. Schizophr Bull Open. 2023. PMID: 39145348 Free PMC article.
-
Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K. Chang L, et al. Biol Psychiatry. 2007 Dec 15;62(12):1396-404. doi: 10.1016/j.biopsych.2007.05.025. Epub 2007 Aug 13. Biol Psychiatry. 2007. PMID: 17693392 Free PMC article.
-
Sun L, Li J, Zhou K, Zhang M, Yang J, Li Y, Ji B, Zhang Z, Zhu H, Yang L, He G, Gao L, Wei Z, Wang K, Han X, Liu W, Tan L, Yu Y, He L, Wan C. Sun L, et al. PLoS One. 2013;8(4):e60598. doi: 10.1371/journal.pone.0060598. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577129 Free PMC article.
-
Yoshida T, McCarley RW, Nakamura M, Lee K, Koo MS, Bouix S, Salisbury DF, Morra L, Shenton ME, Niznikiewicz MA. Yoshida T, et al. Schizophr Res. 2009 Aug;113(1):84-94. doi: 10.1016/j.schres.2009.05.004. Epub 2009 Jun 13. Schizophr Res. 2009. PMID: 19524408 Free PMC article.
-
Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.
da Silva Alves F, Boot E, Schmitz N, Nederveen A, Vorstman J, Lavini C, Pouwels PJ, de Haan L, Linszen D, van Amelsvoort T. da Silva Alves F, et al. PLoS One. 2011;6(6):e21685. doi: 10.1371/journal.pone.0021685. Epub 2011 Jun 30. PLoS One. 2011. PMID: 21738766 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical